These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 27147303)
21. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
22. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates. Simitsopoulou M; Peshkova P; Tasina E; Katragkou A; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E Antimicrob Agents Chemother; 2013 Jun; 57(6):2562-70. PubMed ID: 23529739 [TBL] [Abstract][Full Text] [Related]
23. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089 [TBL] [Abstract][Full Text] [Related]
24. [Activity of micafungin against Candida biofilms]. Quindós G; Villar-Vidal M; Eraso E Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277 [TBL] [Abstract][Full Text] [Related]
25. Activities of nine antifungal agents against Candida auris biofilms. Chatzimoschou A; Giampani A; Meis JF; Roilides E Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284 [TBL] [Abstract][Full Text] [Related]
26. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353 [TBL] [Abstract][Full Text] [Related]
27. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp. Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Bouza E; Guinea J J Antimicrob Chemother; 2017 Jul; 72(7):1969-1976. PubMed ID: 28175309 [TBL] [Abstract][Full Text] [Related]
28. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. DiDone L; Oga D; Krysan DJ Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619 [TBL] [Abstract][Full Text] [Related]
29. Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms. Kovács R; Bozó A; Gesztelyi R; Domán M; Kardos G; Nagy F; Tóth Z; Majoros L Int J Antimicrob Agents; 2016 Apr; 47(4):304-10. PubMed ID: 26968084 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies. Malchikova A; Klyasova G J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758 [TBL] [Abstract][Full Text] [Related]
32. Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms. Guembe M; Guinea J; Marcos-Zambrano LJ; Fernández-Cruz A; Peláez T; Muñoz P; Bouza E Antimicrob Agents Chemother; 2014 Sep; 58(9):5581-4. PubMed ID: 24957821 [TBL] [Abstract][Full Text] [Related]
33. The anthraquinones rubiadin and its 1-methyl ether isolated from Heterophyllaea pustulata reduces Candida tropicalis biofilms formation. Marioni J; da Silva MA; Cabrera JL; Montoya SC; Paraje MG Phytomedicine; 2016 Nov; 23(12):1321-1328. PubMed ID: 27765351 [TBL] [Abstract][Full Text] [Related]
34. Candida tropicalis biofilm's matrix--involvement on its resistance to amphotericin B. Fernandes T; Silva S; Henriques M Diagn Microbiol Infect Dis; 2015 Oct; 83(2):165-9. PubMed ID: 26189843 [TBL] [Abstract][Full Text] [Related]
35. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Seidler M; Salvenmoser S; Müller FM Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265 [TBL] [Abstract][Full Text] [Related]
36. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585 [TBL] [Abstract][Full Text] [Related]
37. Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms. Oliveira AS; Martinez-de-Oliveira J; Donders GGG; Palmeira-de-Oliveira R; Palmeira-de-Oliveira A Med Microbiol Immunol; 2018 Aug; 207(3-4):195-200. PubMed ID: 29556778 [TBL] [Abstract][Full Text] [Related]
38. In vitro combination therapy with isavuconazole against Candida spp. Katragkou A; McCarthy M; Meletiadis J; Hussain K; Moradi PW; Strauss GE; Myint KL; Zaw MH; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ; Petraitis V Med Mycol; 2017 Nov; 55(8):859-868. PubMed ID: 28204571 [TBL] [Abstract][Full Text] [Related]
39. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999 [TBL] [Abstract][Full Text] [Related]
40. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]